Literature DB >> 1087593

Studies on the immune status of children with acute lymphocytic leukaemia. I. Early phase before and after first remission.

W H Hitzig, H J Plüss, P Joller, U Pilgrim, H Tacier-Eugster, M Jakob.   

Abstract

Seventeen children of 2-15 years of age with newly diagnosed untreated acute lymphatic leukaemia (ALL) were evaluated with a number of immunological tests: for humoral immunity serum immunoglobulins and reactive antibody formation against three antigens (diphtheria, tetanus, KLH); for cell-mediated immunity in vitro response of blood lymphocytes against PHA; membrane characteristics of blood lymphocytes and lymphoid blasts for both B and T cells. The tests were repeated in thirteen patients who attained full remission. In the majority (twelve cases) no surface markers were detected (null-cell leukaemia), one patient fulfilled the criteria for a T-cell leukaemia with thymoma. Four patients had rather high absolute B-cell counts, but did not fulfill all the criteria for B-cell leukaemia; three of them died before remission. Immune globulin concentrations were only slightly changed, antibody formation, both primary and anamnestic, was possible. PHA response was extremely low in the initial phase, but normal immediately after remission. During remission all patients were markedly depleted in both their B- and T-cell compartment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087593      PMCID: PMC1540961     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

1.  Studies of proteins and antibodies by specific hemagglutination and hemolysis of proteinconjugated erythrocytes.

Authors:  A B STAVITSKY; E R ARQUILLA
Journal:  Int Arch Allergy Appl Immunol       Date:  1958

2.  Childhood lymphoblastic lymphoma, a cancer of thymus-derived lymphocytes.

Authors:  J Kaplan; R Mastrangelo; W D Peterson
Journal:  Cancer Res       Date:  1974-03       Impact factor: 12.701

3.  Binding of sheep erythrocytes to human lymphocytes. A probable marker of T lymphocytes.

Authors:  S S Fröland
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

4.  Peripheral blood T- and B-lymphocytes in patients with lymphoma and acute leukemia.

Authors:  A H Chin; J H Saiki; J M Trujillo; R C Williams
Journal:  Clin Immunol Immunopathol       Date:  1973-07

Review 5.  Membrane immunoglobulins and antigen receptors on B and T lymphocytes.

Authors:  N L Warner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

6.  Malignant lymphomas of B-cell type.

Authors:  H Stein; K Lennert; M R Parwaresch
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

7.  History of the Sezary syndrome.

Authors:  R K Winkelmann
Journal:  Mayo Clin Proc       Date:  1974-08       Impact factor: 7.616

8.  Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis.

Authors:  L T Yam; C Y Li; K W Lam
Journal:  N Engl J Med       Date:  1971-02-18       Impact factor: 91.245

9.  Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases.

Authors:  W F Piessens; P H Schur; W C Moloney; W H Churchill
Journal:  N Engl J Med       Date:  1973-01-25       Impact factor: 91.245

10.  STUDIES ON RABBIT LYMPHOCYTES IN VITRO. I. STIMULATION OF BLAST TRANSFORMATION WITH AN ANTIALLOTYPE SERUM.

Authors:  S SELL; P G GELL
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  6 in total

1.  Circulating thymic hormone activity in young cancer patients.

Authors:  R Consolini; B Cei; P Cini; E Bottone; L Casarosa
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

2.  Immunoglobulin concentrations in children receiving treatment for acute lymphoblastic leukaemia.

Authors:  M M Reid; A W Craft; J R Cox
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

3.  Studies on the immune status of children with acute lymphocytic leukaemia. II. In remission with and without cytostatic treatment.

Authors:  W H Hitzig; H J Plüss; P Joller; U Pilgrim; H Tacier-Eugster; M Jakob
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

4.  Immunity to herpes simplex virus in children receiving treatment for acute lymphoblastic leukaemia (ALL).

Authors:  P A Tellez; L Odom; A R Hayward
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

5.  Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood.

Authors:  G A de Vaan; P J van Munster; J A Bakkeren
Journal:  Eur J Pediatr       Date:  1982-10       Impact factor: 3.183

6.  Abnormal cellular and humoral immunity in childhood acute lymphoblastic leukemia in long-term remission.

Authors:  J Katz; B N Walter; G A Bennetts; M S Cairo
Journal:  West J Med       Date:  1987-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.